Index Entries - Covid Index

1160 Results

Title	IS Publication Date
Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-up	December 24, 2022
Oxidative Stress and Hyper-Inflammation as Major Drivers of Severe COVID-19 and Long COVID: Implications for the Benefit of High-Dose Intravenous Vitamin C	April 29, 2022
Package insert for Comirnaty and Pfizer-BioNTech COVID-19 Vaccine	Revised September 2023
Package insert for Moderna Spikevax COVID-19 Vaccine	Revised April 2024
PaedVacCOVID - safety of the BNT162b2 vaccine against the SARS-CoV-2 in children with and without comorbidities aged 5 to 11 years	November 11, 2024
Panel of doctors in Nashville, Tennessee	January 2022
Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis	February 16, 2023
Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity	April 9, 2020
Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection	December 17, 2020
Patient Betrayal: The Corruption of Healthcare, Informed Consent and the Physician-Patient Relationship	March 1, 2022
People's COVID-19 Vaccine Inquiry: Witness statement of Dr. Elizabeth Evans, on behalf of the UK Medical Freedom Alliance	April 10, 2024
Perceived Experience in Social Circles with COVID-19 Injections and COVID-19 “Vaccine” Mandates: An Online Survey of the United States Population	February 16, 2024
Persistence of neutralizing antibodies a year after SARS-CoV-2 infection in humans	September 27, 2021
Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection	January 10, 2022
Persistent varicella zoster virus infection following mRNA COVID-19 vaccination was associated with the presence of encoded spike protein in the lesion	August 25, 2022
Perspective: Universal Masking in Hospitals in the Covid-19 Era	May 21, 2020
Pfizer clinical trial: Pfizer-BioNTech COVID-19 BNT162b2 Vaccine Effectiveness Study	First posted April 19, 2021; last updated June 27, 2023
Pfizer Corporate Rap Sheet	Last updated February 3, 2017
Pfizer director admits vaccine was never tested on preventing transmission	October 11, 2022
Pfizer trial paper: Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine	December 10, 2020
Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults by AstraZeneca	updated April 7, 2023
Physicians Declaration – Global COVID Summit, Rome, Italy	September 2021
Physicians Declaration II	October 29, 2021
Pilot study on burden of fungal contamination in face masks: need for better mask hygiene in the COVID-19 era	November 20, 2021
Plaintiffs Motion for Preliminary Injunction: America's Frontline Doctors, et al., vs. Xavier Becerra, Secretary of the U.S. Department of Health and Human Services	July 19, 2021
Plaintiffs Motion for Preliminary Injunction: America’s Frontline Doctors, et al., vs. Xavier Becerra, Secretary of the US Department of Health and Human Services	July 19, 2021
Plastic waste release caused by COVID-19 and its fate in the global ocean	November 8, 2021
Population - With a Disability, 16 Years and over	August 4, 2023
Portal Vein Thrombosis Might Develop by COVID-19 Infection or Vaccination: A Systematic Review of Case-Report Studies	December 14, 2021
Position paper: Use of facemasks in the community as a means to curb the spread of the COVID-19 virus	March 31, 2022
Position Statement on COVID-19 Vaccines for Children	May 8, 2024
Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study	June 24, 2021
Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study	July 28, 2022
Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition	October 5, 2021
Potential adverse effects of nanoparticles on the reproductive system	December 11, 2018
Potential adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech)	May 31, 2021
Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial	June 24, 2021
Potential Links Between the Wuhan Institute of Virology and the Origin of the COVID-19 Pandemic	June 2023
Potential toxicity of nanoparticles on the reproductive system animal models	September 25, 2021
Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children	August 18, 2021
Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID-19 illness	February 3, 2022
Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples	May 22, 2020
Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California	January 10, 2022
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans	December 11, 2020
Prenatal Exposure to COVID-19 mRNA Vaccine BNT162b2 Induces Autism-Like Behaviors in Male Neonatal Rats: Insights into WNT and BDNF Signaling Perturbations	January 10, 2024
PREP Act 5th Amendment	January 28, 2021
Preparedness for a High-Impact Respiratory Pathogen Pandemic	September 18, 2019
Presence of viral spike protein and vaccinal spike protein in the blood serum of patients with long-COVID syndrome	December 27, 2023
Press Briefing by White House COVID-19 Response Team and Public Health Officials	December 29, 2021
Press conference - Cause of Death after COVID-19 Vaccination and Undeclared Components of the COVID-19 Vaccines	September 20, 2021

Page 15 of 24